Furthermore, the evaluation of DNA-methylation in cell-free DNA seems to be superior to cancer antigen 125 (CA125) as a tool of evaluation of ovarian cancer risk and in discerning healthy women from ovarian cancer patients [108]. The gene discussed is MUC16; the disease is ovarian cancer.